The top activity for fund was in 2019. Deals in the range of 5 - 10 millions dollars are the general things for fund. The fund is constantly included in 2-6 deals per year.
The usual cause for the fund is to invest in rounds with 7 partakers. Despite the Techgate, startups are often financed by The FSE Group, Oxford Capital Partners, Octopus Ventures. The meaningful sponsors for the fund in investment in the same round are eCAPITAL entrepreneurial Partners AG, Seraphim Capital, Oxford Capital Partners. In the next rounds fund is usually obtained by Innovate UK, eCAPITAL entrepreneurial Partners AG, Seraphim Capital.
The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight UltraSoC Technologies, UltraSoC Technologies. We can highlight the next thriving fund investment areas, such as Infrastructure, Cyber Security. Moreover, a startup needs to be at the age of 11-15 years to get the investment from the fund.
| Fund Name | Location |
| B. Braun Medical | Bethlehem, Pennsylvania, United States |
| Daji Renhe | Beijing, Beijing, China |
| Dale Ventures | Dubai, United Arab Emirates |
| Evergreen Coast Capital | California, Menlo Park, United States |
| Hanhui Touzi | China, Guangdong, Guangzhou |
| Hanover Technology Investment Management | California, Menlo Park, United States |
| Junlian Yikang | Beijing, China, Haidian |
| Qiaojing Capital | China, Shanghai |
| Techspring Partners | - |
| True Partners Consulting | Chicago, Illinois, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 